View in EDS HTML Full Text PDF Full Text

A single‐day polychemotherapy regimen with proteasome inhibitor combinations for relapsed/refractory myeloma in the era of novel therapies.

Saved in:
Bibliographic Details
Title: A single‐day polychemotherapy regimen with proteasome inhibitor combinations for relapsed/refractory myeloma in the era of novel therapies.
Authors: Li, Eric Wenlong1,2 (AUTHOR), Jones, Esther1 (AUTHOR), Bryant, Christian1,2 (AUTHOR), King, Tracy1,2 (AUTHOR), Talaulikar, Dipti3,4 (AUTHOR), Ng, Jun Yen3 (AUTHOR), Bryant, Adam5 (AUTHOR), Ridha, Zainab5 (AUTHOR), Doo, Nicole Wong2,6 (AUTHOR), Menzies, Anna7 (AUTHOR), Ling, Silvia5,8 (AUTHOR), Ho, Shir Jing7 (AUTHOR), Abadir, Edward1,2 (AUTHOR), Vanguru, Vinay1,2 (AUTHOR), Joshua, Douglas1,2 (AUTHOR), Ho, P. Joy1,2 (AUTHOR) joy.ho1@health.nsw.gov.au
Source: European Journal of Haematology. Oct2024, Vol. 113 Issue 4, p521-529. 9p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:09024441
DOI:10.1111/ejh.14266